<div id="readability-page-1"><div>Global biotin ingredients market grows with rising demand from pharmaceuticals, supplements, and beauty products, driven by wellness trends and advanced formulations NEWARK, DE / ACCESS Newswire / March 18, 2026 / According to analysis by Future Market Insights (FMI), the global biotin ingredients market is entering a phase of accelerated expansion as demand converges across nutraceutical, pharmaceutical, and beauty-from-within product segments. Rising consumer awareness around hair, skin, and nail health, combined with increasing pharmaceutical applications, is reshaping procurement and formulation strategies across industries.The market was valued at USD 3.40 billion in 2025 and is projected to reach USD 3.77 billion in 2026. Over the forecast period, demand is expected to grow at a robust CAGR of 10.90%, ultimately reaching USD 10.61 billion by 2036.This strong growth trajectory reflects a structural shift toward preventive healthcare and functional nutrition. Rather than serving as a niche vitamin ingredient, biotin is increasingly being positioned as a core functional component across supplements, cosmetics, fortified foods, and pharmaceutical formulations.Get Access of Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-25713 <img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/imagelibrary/3a1bdc15-8c43-421f-aa85-ff77528041aa/1148794/image.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1536" height="1024" original-src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/imagelibrary/3a1bdc15-8c43-421f-aa85-ff77528041aa/1148794/image.png"/> Biotin Ingredients Market Snapshot<ul><li>Market Value (2025): USD 3.40 Billion</li><li>Forecast Value (2036): USD 10.61 Billion</li><li>Forecast CAGR (2026-2036): 10.90%</li><li>Leading Type: Solid Biotin (71.3%)</li><li>Top Application Segment: Pharmaceutical (34.0%)</li><li>Leading Distribution Channel: Direct Sales (46.5%)</li><li>Fastest Growing Market: China</li></ul>Beauty-from-Within Trends Driving Ingredient DemandA primary force driving the biotin ingredients market is the rapid rise of beauty-from-within trends, where consumers increasingly rely on ingestible supplements for visible improvements in hair, skin, and nail health.Manufacturers are responding by developing high-dose, bioavailable formulations that deliver measurable outcomes. At the same time, pharmaceutical demand remains strong due to biotin's established role in treating biotinidase deficiency and metabolic disorders.FMI analysts note that this dual demand-clinical and cosmetic-is elevating biotin from a commodity vitamin to a high-value functional ingredient.Supply Chain Concentration and Quality Specifications Shape ProcurementProcurement strategies are increasingly influenced by supply chain concentration and stringent quality requirements. A significant portion of global biotin production is concentrated among fermentation-based manufacturers in China, creating sourcing risks for pharmaceutical-grade material.Key procurement challenges include:<ul><li>Ensuring pharmacopoeia-grade purity and regulatory compliance</li><li>Managing price volatility linked to fermentation feedstock costs</li><li>Mitigating single-source supply risks</li></ul>As a result, pharmaceutical and cosmetic manufacturers are increasingly adopting dual-sourcing strategies and long-term supplier agreements to ensure consistency and security.Solid Biotin Leads Product SegmentBy type, solid biotin is projected to dominate the market with a 71.3% share in 2026.Its leadership is driven by operational advantages such as:<ul><li>Superior stability during storage and processing</li><li>Ease of handling in tableting and capsule filling</li><li>Precise dosing capabilities for pharmaceutical and nutraceutical applications</li></ul>These benefits make solid biotin the preferred format across large-scale manufacturing environments.Pharmaceutical Segment Drives Application DemandThe pharmaceutical segment is expected to hold the largest share, accounting for 34.0% of total demand in 2026.This dominance is supported by:<ul><li>Established therapeutic use in biotin deficiency treatment</li><li>Growing off-label use in high-dose wellness formulations</li><li>Increasing demand for clinically validated ingredients</li></ul>Pharmaceutical-grade biotin continues to command premium pricing due to strict quality specifications and regulatory requirements.Direct Sales Channel Dominates DistributionBy distribution channel, direct sales are projected to account for 46.5% of the market in 2026.This reflects the B2B nature of the industry, where manufacturers procure ingredients directly from API suppliers under long-term quality agreements.Meanwhile, online channels are emerging as the fastest-growing segment, enabling smaller supplement brands to source ingredients more efficiently and bypass traditional intermediaries.Asia-Pacific Emerges as a High-Growth RegionRegionally, the biotin ingredients market is witnessing strong growth across Asia-Pacific, driven by expanding manufacturing capacity and rising consumer demand for wellness products.Biotin Ingredients Market Growth by Country (2026-2036)<ul><li>China: 14.7%</li><li>India: 13.6%</li><li>Germany: 12.5%</li><li>France: 11.4%</li><li>United Kingdom: 10.4%</li><li>United States: 9.3%</li><li>Brazil: 8.2%</li></ul>China leads global growth, supported by large-scale fermentation production and increasing domestic consumption. India follows closely, driven by rising awareness of nutritional supplements and expanding middle-class demand.Innovation in Bioavailability and Formulation Unlocking OpportunitiesTechnological advancements are enhancing the performance and application scope of biotin ingredients. Manufacturers are investing in advanced encapsulation techniques and delivery systems to improve bioavailability and stability.At the same time, integration into functional foods and beverages is opening new revenue streams, with applications expanding into protein drinks, cereals, and fortified snacks.These innovations are positioning biotin as a versatile ingredient across multiple end-use industries.Key Players in the Biotin Ingredients MarketLeading companies operating in the global market include:<ul><li>DSM</li><li>Lonza</li><li>BASF</li><li>Merck</li><li>Evonik</li><li>Archer Daniels Midland (ADM)</li><li>Cargill</li><li>Ingredion</li><li>Glanbia Nutritionals</li><li>Kerry Group</li><li>Brenntag</li><li>IMCD</li><li>Prinova Group</li><li>Balchem</li><li>Associated British Foods (ABF)</li></ul>These players are focusing on high-purity formulations, regulatory compliance, and global supply chain capabilities to strengthen their competitive positioning.Market Outlook: Biotin Becomes Core to Wellness FormulationsThe long-term outlook for the biotin ingredients market remains highly positive as demand for preventive healthcare, functional nutrition, and beauty supplements continues to rise.With increasing integration across pharmaceuticals, nutraceuticals, cosmetics, and functional foods, biotin is transitioning from a supplementary ingredient to a foundational component in modern wellness product development.As innovation in formulation, sourcing strategies, and delivery mechanisms accelerates, the market is set for sustained high-growth through 2036-cementing biotin's role as a key driver in next-generation health and beauty solutions.For an in-depth analysis of evolving formulation trends and to access the complete strategic outlook for the Biotin Ingredients Market through 2036, Full Report Request - https://www.futuremarketinsights.com/reports/biotin-ingredients-marketRelated Reports:Biotin Supplement Market: https://www.futuremarketinsights.com/reports/biotin-supplements-marketBiotin Gummies Market: https://www.futuremarketinsights.com/reports/biotin-gummies-marketMilk Ingredients Market: https://www.futuremarketinsights.com/reports/milk-ingredients-marketMalt Ingredients Market: https://www.futuremarketinsights.com/reports/malt-ingredients-marketBean Ingredients Market: https://www.futuremarketinsights.com/reports/bean-ingredients-marketAbout Future Market Insights (FMI)Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.For Press &amp; Corporate InquiriesRahul Singh AVP - Marketing and Growth Strategy Future Market Insights, Inc. +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/SOURCE: Future Market Insights, Inc.View the original press release on ACCESS Newswire <img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTE0ODc5NA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTE0ODc5NA"/></div></div>

動態生物技術與基因組 ETF - Invesco

醫藥突破 ETF - ALPS

全球生物素成分市場預計將從 2025 年的 34 億美元增長到 2036 年的 106.1 億美元，年均增長率為 10.90%。這一增長受到製藥、補充劑和美容產品需求上升的推動，受健康趨勢的影響。固體生物素預計將主導市場，而製藥部門將佔據最大份額。亞太地區，特別是中國和印度，正成為一個高增長區域。主要參與者包括 DSM、Lonza 和 BASF，專注於高純度配方和合規性

Biotin Ingredients Market Outlook 2026-2036: Global Market to Reach USD 10.61 Billion by 2036 at 10.90% CAGR | FMI Report

MorningStar

Symrise AG

標普生物技術 ETF - SPDR

龍沙

SNP Schneider-Neureither & Partner SE

標普生物技術 3 倍做多 - Direxion

巴斯夫

巴斯夫(ADR)

2 倍做多納斯達克生物技術 ETF - ProShares

生物科技 ETF - VanEck Vectors

紐交所高增長板生物技術指數 ETF - First Trust

SANOCHEMIA Pharmazeutika AG

納斯達克生物科技指數 ETF - iShares Nasdaq

Lonza

生物素成分市場展望 2026-2036：根據 FMI 報告，全球市場預計到 2036 年將達到 106.1 億美元，年複合增長率為 10.90%